Company intelligence / Profile preview

Atlantic Therapeutics

Galway, Connaught, Irelanduk.myinnovo.com ↗

Ownership: Private
Employees: ~29
Development stage: Other

Overview

Atlantic Therapeutics developed INNOVO, a wearable non-invasive neuromuscular electrical stimulation device for strengthening pelvic floor muscles to treat stress urinary incontinence. Clinical trials with over 600 subjects demonstrated significant improvements in symptoms and acceptability. The product is FDA-approved and commercially available across multiple regions.

Therapeutic areas: NephrologyWomen's Health
Modalities: DeviceNon-pharmacological therapyNeuromuscular electrical stimulation device (NMES)
Industry: Therapeutic Medical Devices

Partnerships

University College Dublin (UCD) – academic collaboration/licensing partner for core technology/IP transfer

Beyond the preview

Go deeper on Atlantic Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Atlantic Therapeutics.

Explore the full profile